Show Stocks and Investing Publications • Fri, May 5, 2023
Travis Steed Downgraded (TNDM) to Sell and Decreased Target to $33 on, May 5th, 2023
teed-downgraded-tndm-to-sell-and-decreased-target-to-33-on-may-5th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAITravis Steed of B of A Securities, Downgraded "Tandem Diabetes Care, Inc." (TNDM) to Sell and Decreased Target from $45 to $33 on, May 5th, 2023.
Travis has made no other calls on TNDM in the last 4 months.
There are 7 other peers that have a rating on TNDM. Out of the 7 peers that are also analyzing TNDM, 5 agree with Travis's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeff Johnson of "Baird" Maintained at Hold with Decreased Target to $38 on, Thursday, May 4th, 2023
- Larry Biegelsen of "Wells Fargo" Maintained at Hold with Decreased Target to $40 on, Thursday, May 4th, 2023
- Jayson Bedford of "Raymond James" Downgraded from Buy to Hold on, Monday, April 24th, 2023
- Danielle Antalffy of "UBS" Initiated at Hold and Held Target at $45 on, Wednesday, March 29th, 2023
- Mike Polark of "Wolfe Research" Initiated at Hold on, Thursday, January 26th, 2023
These are the ratings of the 2 analyists that currently disagree with Travis
- Joshua Jennings of "Cowen & Co." Maintained at Buy with Decreased Target to $52 on, Thursday, February 23rd, 2023
- Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $50 on, Thursday, February 23rd, 2023
Like: 👍